amr-review.org

What It Is

amr-review.org is the official archive website of “The Review on Antimicrobial Resistance.” The review was commissioned in 2014 by the UK Prime Minister, chaired by economist Jim O’Neill, and supported by the UK government and the Wellcome Trust. Its goal was to analyze the global threat of antimicrobial resistance (AMR) from economic and social perspectives and propose recommendations for international action. The site clearly states that the project has been completed and that its content has been frozen as an archive and is no longer updated.

Core Features

The website mainly provides background information on the AMR Review, the project’s terms of reference, information about the chair and advisory team, industry publications, infographics, media resources, and the final report. The most important content is the 2016 final report, Tackling Drug-Resistant Infections Globally, along with supporting research papers. These cover topics such as the economic impact of antibiotic resistance, rapid diagnostics, vaccines, sanitation and hygiene, agricultural pollution, global surveillance, market entry rewards, and innovation funds.

Pricing

This is not a commercial service and has no membership, subscription, or paid download model. Reports and web materials are freely available to the public, making the site suitable for policy research, academic citation, and media background research.

Pros and Cons

Its strengths are its authoritative source and the backing of the UK government, the Wellcome Trust, and an international network of public health experts. The content focuses on the macroeconomic and policy governance aspects of AMR, offering a perspective more suitable for decision-making analysis than purely medical materials. The drawbacks are also clear: the project ended years ago, the site is no longer updated, and it does not reflect the latest AMR data or policy developments. The pages are relatively static, with limited search, data visualization, and interactive capabilities. The content is mainly in English, which may pose a barrier for Chinese readers.

Who It’s For

It is suitable for public health policymakers, pharmaceutical R&D strategy professionals, health economics researchers, international organization staff, journalists, and students or researchers who need to cite global action recommendations on AMR. It is not suitable as a source for real-time outbreak information, clinical treatment guidelines, or the latest antimicrobial drug databases.

Access in China

Judging from the nature of the site and publicly available information, it is a standard English-language public health archive and is generally accessible directly. However, because hosting arrangements and external PDF links may change over time, some resources may load slowly or become unavailable. Overall, this is a highly authoritative but statically archived AMR policy research repository with strong historical reference value. For up-to-date information, it should be supplemented with the latest sources from organizations such as the WHO, CDC, and ECDC.